• Type:
  • Category:

Carl Zeiss Meditec AG Financial Results 9M 2021 / 22 | Performance & Future Growth with CEO and CFO

Share

Excerpt

Discover the impressive 9M-21/22 financial results of Carl Zeiss Meditec AG, a global leader in medical technology. This comprehensive summary will dive into the company’s remarkable growth, revenue milestones, and future outlook.

 

CEO Markus Weber and CFO Justus Felix Wehmer share their insights on key drivers behind this success and strategies for continued innovation.

 

Don’t miss this exclusive opportunity to learn about Carl Zeiss Meditec’s thriving business and how they are shaping the industry’s future.

Company Profile

The Medical Technology activities of ZEISS are bundled under the umbrella of the MDAX- and TecDAX-listed company Carl Zeiss Meditec AG. With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network. Two Pillars of Business & Markets: The main activities of Carl Zeiss Meditec AG are located in the field of Ophthalmology and Microsurgery In Ophthalmology, the Company offers mainly products and solutions for the diagnosis and treatment of eye diseases, as well as systems and consumables for cataract, retinal and refractive surgery. In Microsurgery the Carl Zeiss Meditec Group provides visualization solutions for minimally invasive surgical treatments. Markets: The Carl Zeiss Meditec Group has operations all over the world. With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world’s most important markets. Milestones & Innovations: Research and development plays an important role within the Carl Zeiss Meditec Group. Our objective is to enable our customers and physicians to continuously improve treatment results through improvements in efficiency and innovative new products

Carl Zeiss Meditec AG

Goeschwitzer Strasse 51-52

Jena 07745, Germany

phone +49 3641 220 116

Resources

Presentation
Carl Zeiss Meditec Video Library
Podcast

Host

Dr. Markus Weber
CEO | Carl Zeiss Meditec AG

Justus Felix Wehmer
CFO | Carl Zeiss Meditec AG

Linkedin

Sebastian Frericks
Head IR | Carl Zeiss Meditec AG

Linkedin Envelope

Share

T&C:

This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/

More Elevator Pitches

More Company Presentations

Release Date

August 5, 2022

Duration

02:51

Director

Reviews for Carl Zeiss Meditec AG Financial Results 9M 2021 / 22 | Performance & Future Growth with CEO and CFO

There are currently no reviews for Carl Zeiss Meditec AG Financial Results 9M 2021 / 22 | Performance & Future Growth with CEO and CFO
COMPANIES:

Austria:

Estonia:

Germany:

Hypoport SE

Jost Werke AG

Knaus Tabbert AG

LEG Immobilien SE

Media and Games Invest SE

Mister Spex SE

Mountain Alliance AG

Multitude SE

Mutares SE & Co. KGaA

Nemetschek SE

Rational AG

Schaltbau Holding AG

SFC Energy AG

Sixt SE

Talanx AG

Varta AG

voxeljet AG

Wacker Chemie AG

Zeal Network SE

Italy:

Poland:

INDEX:

Austria:

Estonia:

Switzerland:

USA:

Germany:

Poland:

VERTICALS:
INDUSTRIES:
Linkedin Twitter Podcast Envelope Whatsapp

💺 seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG 

Unlock the insights of top publicly listed companies with seat11a.com

Elevate your understanding with powerful Elevator Pitches, Deep-Dive Presentations, and in-depth Financial Analysis

Scroll to top